1. Home
  2. CDNA vs MMI Comparison

CDNA vs MMI Comparison

Compare CDNA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$17.75

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

MMI

Marcus & Millichap Inc.

N/A

Current Price

$26.83

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
MMI
Founded
1998
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
CDNA
MMI
Price
$17.75
$26.83
Analyst Decision
Buy
Sell
Analyst Count
7
2
Target Price
$27.33
$28.00
AVG Volume (30 Days)
591.0K
299.1K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
1.88%
EPS Growth
N/A
84.38
EPS
N/A
N/A
Revenue
$48,324,000.00
$719,700,000.00
Revenue This Year
$15.37
$14.04
Revenue Next Year
$11.23
$11.35
P/E Ratio
N/A
N/A
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$24.43
52 Week High
$21.49
$36.70

Technical Indicators

Market Signals
Indicator
CDNA
MMI
Relative Strength Index (RSI) 37.96 56.08
Support Level $16.74 $24.89
Resistance Level $18.02 $27.32
Average True Range (ATR) 0.85 0.89
MACD -0.13 0.14
Stochastic Oscillator 23.20 91.18

Price Performance

Historical Comparison
CDNA
MMI

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Share on Social Networks: